La Neve Stephen R. 4
4 · Bone Biologics Corp · Filed Mar 20, 2018
Insider Transaction Report
Form 4
La Neve Stephen R.
DirectorCEO and President
Transactions
- Award
Restricted Stock Unit
2018-02-16+142,132→ 176,546 totalExercise: $0.00→ Common Stock (142,132 underlying)
Footnotes (1)
- [F1]On February 16, 2018, the Reporting Person was granted 142,132 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person is still providing services to the issuer on the respective date.